A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Director – Business Development - Transactions

Corporate StrategyConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA$204k - $276k

About the Job

Requirements

  • A bachelor's degree is required; a life science or business discipline is preferred. An MBA, JD, or other advanced degree is preferred.
  • At least 8–10+ years of relevant experience in the biopharmaceutical industry or related fields, including consulting or investment banking, with at least 3–5 years of direct business development experience and a proven track record of leading deals. A detailed dealsheet is required.
  • Strong understanding of the drug development process and biotechnology and pharmaceutical industry dynamics, including market trends, the regulatory environment, the macro deal-making environment, and their business impact.
  • Ability to integrate scientific knowledge into business cases, including analyzing and interpreting commercial forecasts, profit and loss statements, risk assessments, and other financial valuation methodologies.
  • Strong term sheet development, project management, and contract negotiation skills.
  • Ability to synthesize complex information into clear strategic insights, frame strategic tradeoffs, and influence decision-making, with strong attention to detail and execution rigor.
  • Excellent communication, presentation, and problem-solving skills and executive presence, with the ability to influence internal and external stakeholders at all levels.

Responsibilities

  • Identify and evaluate potential business development opportunities, including in-licensing, out-licensing, and strategic partnerships.
  • Lead and support strategic, financial, and commercial assessments of opportunities, including valuation and deal structuring.
  • Manage transaction execution, including due diligence coordination, term sheet development, and negotiation.
  • Develop materials for internal governance, such as investment committees, and senior leadership presentations.
  • Collaborate with internal stakeholders across research and development, Commercial, Legal, and Finance to assess strategic fit and risks.
  • Maintain and expand the external network with biotechnology and pharmaceutical companies, advisors, and other partners.
  • Support alliance management activities after deal execution, as needed.

Desired Qualifications

  • A life science or business discipline, an MBA, JD, or other advanced degree.
  • A scientific background or strong aptitude to rapidly understand complex science and emerging technologies.
  • Prior people management experience.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs